Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ruba Alajlouni
Institution:
Improved Pharma (United States)
Observed institutions:
Improved Pharma (United States),
Virginia Tech
ORCID:
0000-0002-8829-9937
Observed ORCID:
0000-0002-8829-9937
OpenAlex ID:
A5025040266
Works
7
Awards
1
Lipid-mediated membrane binding properties of Disabled-2
2011
·
Ruba Alajlouni
, Karen E. Drahos
, et al.
·
Biochimica et Biophysica Acta (BBA) - Biomembranes
·
21
Return of the Ritonavir: A Study on the Stability of Pharmaceuticals Processed in Orbit and Returned to Earth
2024
·
Haley C. Bauser
, Pamela A. Smith
, et al.
·
ChemRxiv
·
7
A study on the stability of ritonavir form III processed in orbit and returned to Earth
2026
·
Haley C. Bauser
, Pamela A. Smith
, et al.
·
npj Microgravity
·
3
PDF
Return of the Ritonavir: A Study on the Stability of Pharmaceuticals Processed in Orbit
2024
·
Haley C. Bauser
, Pamela A. Smith
, et al.
·
ChemRxiv
·
2
Return of the Ritonavir: A Study on the Stability of Pharmaceuticals Processed in Orbit
2024
·
Haley C. Bauser
, Pamela A. Smith
, et al.
·
ChemRxiv
·
1
PDF
Lipid-Dependent Membrane-Mediated Function of Disabled-2
2012
·
Daniel G. Capelluto
, Shuyan Xiao
, et al.
·
Biophysical Journal
PDF
Membrane binding properties of Disabled-2
2011
·
Ruba Alajlouni
·
VTechWorks (Virginia Tech)
Show more works
View as search
Works count:
7
Citation count:
34
H-index:
3
I10-index:
1
Year
Topic
Type